KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Tax Provisions (2016 - 2022)

Historic Tax Provisions for Arbutus Biopharma (ABUS) over the last 6 years, with Q1 2022 value amounting to $4.4 million.

  • Arbutus Biopharma's Tax Provisions changed N/A to $4.4 million in Q1 2022 from the same period last year, while for Dec 2022 it was $4.4 million, marking a year-over-year change of. This contributed to the annual value of $4.4 million for FY2022, which is N/A changed from last year.
  • Per Arbutus Biopharma's latest filing, its Tax Provisions stood at $4.4 million for Q1 2022.
  • Over the past 5 years, Arbutus Biopharma's Tax Provisions peaked at $4.4 million during Q1 2022, and registered a low of -$12.7 million during Q3 2019.
  • Its 3-year average for Tax Provisions is -$4.2 million, with a median of -$4.3 million in 2018.
  • The largest annual percentage gain for Arbutus Biopharma's Tax Provisions in the last 5 years was 19556.28% (2019), contrasted with its biggest fall of 19556.28% (2019).
  • Over the past 3 years, Arbutus Biopharma's Tax Provisions (Quarter) stood at -$4.3 million in 2018, then crashed by 195.56% to -$12.7 million in 2019, then soared by 135.11% to $4.4 million in 2022.
  • Its Tax Provisions was $4.4 million in Q1 2022, compared to -$12.7 million in Q3 2019 and -$4.3 million in Q3 2018.